abiraterone acetate and prednisone/dexamethasone with docetaxel


( Last Updated : July 7, 2022)
Generic Name:
abiraterone acetate and prednisone/dexamethasone with docetaxel
Project Status:
Received
Therapeutic Area:
Metastatic castration sensitive prostate cancer (mCSPC).
Manufacturer:
N/A
Call for patient/clinician input open:
Brand Name:
N/A
Project Line:
Reimbursement Review
Project Number:
PC0298-000
Call for patient/clinician input closed:
Tumour Type:
Genitourinary

Details


Submission Type:
Non-sponsored Submission
Indications:
For the treatment of metastatic castration sensitive prostate cancer in combination with androgen deprivation therapy.

Key Milestones

Call for patient/clinician input open 07-July-22
Call for patient/clinician input closed 26-Aug-22
Call for Industry feedback open 07-July-22
Call for industry feedback closed 26-Aug-22